EUVIMEDEUVIMED entdecken
Crossref

Imipenem reduces the efficacy of vancomycin against Elizabethkingia species

Ya-Sung Yang, Hsing-Yu Chen, I Chieh Lin, Meng-He Lin, Wei-Yao Wang, Shu-Chen Kuo iD, Wen-Ting Chen, Yun-Hsiang Cheng, Jun-Ren Sun iD

Journal of Antimicrobial Chemotherapy · 2024

DOI: 10.1093/jac/dkae210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Ya-Sung Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center…. Hauptthemen laut MEDLINE: Imipenem, Anti-Bacterial Agents, Biofilms, Vancomycin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Ministry of National Defense, National Science and Technology Council, Taiwan, Tri-Service General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Elizabethkingia spp. are emerging as nosocomial pathogens causing various infections. These pathogens express resistance to a broad range of antibiotics, thus requiring antimicrobial combinations for coverage. However, possible antagonistic interactions between antibiotics have not been thoroughly explored. This study aimed to evaluate the effectiveness of antimicrobial combinations against Elizabethkingia infections, focusing on their impact on pathogenicity, including biofilm production and cell adhesion.

Methods

Double-disc diffusion, time–kill, and chequerboard assays were used for evaluating the combination effects of antibiotics against Elizabethkingia spp. We further examined the antagonistic effects of antibiotic combinations on biofilm formation and adherence to A549 human respiratory epithelial cells. Further validation of the antibiotic interactions and their implications was performed using ex vivo hamster precision-cut lung sections (PCLSs) to mimic in vivo conditions.

Results

Antagonistic effects were observed between cefoxitin, imipenem and amoxicillin/clavulanic acid in combination with vancomycin. The antagonism of imipenem toward vancomycin was specific to its effects on the genus Elizabethkingia. Imipenem further hampered the bactericidal effect of vancomycin and impaired its inhibition of biofilm formation and the adhesion of Elizabethkingia meningoseptica ATCC 13253 to human cells. In the ex vivo PCLS model, vancomycin exhibited dose-dependent bactericidal effects; however, the addition of imipenem also reduced the effect of vancomycin.

Conclusions

Imipenem reduced the bactericidal efficacy of vancomycin against Elizabethkingia spp. and compromised its capacity to inhibit biofilm formation, thereby enhancing bacterial adhesion. Clinicians should be aware of the potential issues with the use of these antibiotic combinations when treating Elizabethkingia infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImipenemAnti-Bacterial AgentsBiofilmsVancomycinMicrobial Sensitivity TestsFlavobacteriaceae InfectionsAnimalsHumansFlavobacteriaceaeBacterial AdhesionA549 CellsCricetinaeDrug InteractionsLung

Substanzen

ImipenemAnti-Bacterial AgentsVancomycin

Autor:innen und Institutionen

  • Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Department of Medical Techniques, Taipei City Hospital Ren-Ai Branch, Taipei, Taiwan.
  • National Defense Medical Center, Institute of Preventive Medicine, Taipei, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan.

ORCID-Profile: Shu-Chen Kuo, Jun-Ren Sun

Förderung

  • Ministry of National Defense
  • National Science and Technology Council, Taiwan
  • Tri-Service General Hospital
  • Chi Mei Medical Center
  • Taipei City Hospital

Zitieren

APA

Yang, Y. S., Chen, H. Y., Lin, I. C., Lin, M. H., Wang, W. Y., Kuo, S. C., Chen, W. T., Cheng, Y. H., & Sun, J. R. (2024). Imipenem reduces the efficacy of vancomycin against Elizabethkingia species. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae210

Vancouver

Yang YS, Chen HY, Lin IC, Lin MH, Wang WY, Kuo SC, et al. Imipenem reduces the efficacy of vancomycin against Elizabethkingia species. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae210

BibTeX
@article{Yang2024,
  author = {Yang, Ya-Sung and Chen, Hsing-Yu and Lin, I Chieh and Lin, Meng-He and Wang, Wei-Yao and Kuo, Shu-Chen and Chen, Wen-Ting and Cheng, Yun-Hsiang and Sun, Jun-Ren},
  title = {Imipenem reduces the efficacy of vancomycin against Elizabethkingia species},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  doi = {10.1093/jac/dkae210}
}
Kostenlos starten →